-
Je něco špatně v tomto záznamu ?
STRC Gene Mutations, Mainly Large Deletions, are a Very Important Cause of Early-Onset Hereditary Hearing Loss in the Czech Population
SP. Marková, DŠ. Brožková, P. Laššuthová, A. Mészárosová, M. Krůtová, J. Neupauerová, D. Rašková, M. Trková, D. Staněk, P. Seeman,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
NV16-31173A
MZ0
CEP - Centrální evidence projektů
PubMed
29425068
DOI
10.1089/gtmb.2017.0155
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- membránové proteiny genetika MeSH
- mutace * MeSH
- nedoslýchavost genetika MeSH
- polymerázová řetězová reakce MeSH
- sekvenční delece MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
INTRODUCTION: Hearing loss (HL) is the most common sensory deficit in humans. HL is an extremely heterogeneous condition presenting most frequently as a nonsyndromic (NS) condition inherited in an autosomal recessive (AR) pattern, termed DFNB. Mutations affecting the STRC gene cause DFNB type 16. Various types of mutations within the STRC gene have been reported from the U.S. and German populations, but no information about the relative contribution of STRC mutations to NSHL-AR among Czech patients is available. METHODS AND PATIENTS: Two hundred and eighty-eight patients with prelingual NSHL, either sporadic (n = 207) or AR (n = 81), who had been previously tested negative for the mutations affecting the GJB2 gene, were included in the study. These patients were tested for STRC mutations by a quantitative comparative fluorescent polymerase chain reaction (QF-PCR) assay. In addition, 31 of the 81 NSHL-AR patients were analyzed by massively parallel sequencing using one of two different gene panels: 23 patients were analyzed by multiplex-ligation probe amplification (MLPA); and 9 patients by SNP microarrays. RESULTS: Causal mutations affecting the STRC gene (including copy number variations [CNVs] and point mutations) were found in 5.5% of all patients and 13.6% of the 81 patients in the subgroup with NSHL-AR. CONCLUSION: Our results provide strong evidence that STRC gene mutations are an important cause of NSHL-AR in Czech HL patients and are probably the second most common cause of DFNB. Large CNVs were more frequent than point mutations and it is reasonable to test them first by a QF-PCR method-a simple, accessible, and efficient tool for STRC CNV detection, which can be combined by MLPA.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033328
- 003
- CZ-PrNML
- 005
- 20200923170549.0
- 007
- ta
- 008
- 181008s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/gtmb.2017.0155 $2 doi
- 035 __
- $a (PubMed)29425068
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Marková, Simona Poisson $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University in Prague , Prague, Czech Republic .
- 245 10
- $a STRC Gene Mutations, Mainly Large Deletions, are a Very Important Cause of Early-Onset Hereditary Hearing Loss in the Czech Population / $c SP. Marková, DŠ. Brožková, P. Laššuthová, A. Mészárosová, M. Krůtová, J. Neupauerová, D. Rašková, M. Trková, D. Staněk, P. Seeman,
- 520 9_
- $a INTRODUCTION: Hearing loss (HL) is the most common sensory deficit in humans. HL is an extremely heterogeneous condition presenting most frequently as a nonsyndromic (NS) condition inherited in an autosomal recessive (AR) pattern, termed DFNB. Mutations affecting the STRC gene cause DFNB type 16. Various types of mutations within the STRC gene have been reported from the U.S. and German populations, but no information about the relative contribution of STRC mutations to NSHL-AR among Czech patients is available. METHODS AND PATIENTS: Two hundred and eighty-eight patients with prelingual NSHL, either sporadic (n = 207) or AR (n = 81), who had been previously tested negative for the mutations affecting the GJB2 gene, were included in the study. These patients were tested for STRC mutations by a quantitative comparative fluorescent polymerase chain reaction (QF-PCR) assay. In addition, 31 of the 81 NSHL-AR patients were analyzed by massively parallel sequencing using one of two different gene panels: 23 patients were analyzed by multiplex-ligation probe amplification (MLPA); and 9 patients by SNP microarrays. RESULTS: Causal mutations affecting the STRC gene (including copy number variations [CNVs] and point mutations) were found in 5.5% of all patients and 13.6% of the 81 patients in the subgroup with NSHL-AR. CONCLUSION: Our results provide strong evidence that STRC gene mutations are an important cause of NSHL-AR in Czech HL patients and are probably the second most common cause of DFNB. Large CNVs were more frequent than point mutations and it is reasonable to test them first by a QF-PCR method-a simple, accessible, and efficient tool for STRC CNV detection, which can be combined by MLPA.
- 650 _2
- $a nedoslýchavost $x genetika $7 D034381
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a membránové proteiny $x genetika $7 D008565
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a sekvenční delece $7 D017384
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Brožková, Dana Šafka $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University in Prague , Prague, Czech Republic .
- 700 1_
- $a Laššuthová, Petra $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University in Prague , Prague, Czech Republic .
- 700 1_
- $a Mészárosová, Anna $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University in Prague , Prague, Czech Republic .
- 700 1_
- $a Krůtová, Marcela $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University in Prague , Prague, Czech Republic .
- 700 1_
- $a Neupauerová, Jana $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University in Prague , Prague, Czech Republic .
- 700 1_
- $a Rašková, Dagmar $u 2 Gennet , Prague, Czech Republic .
- 700 1_
- $a Trková, Marie $u 2 Gennet , Prague, Czech Republic .
- 700 1_
- $a Staněk, David $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University in Prague , Prague, Czech Republic .
- 700 1_
- $a Seeman, Pavel $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University in Prague , Prague, Czech Republic .
- 773 0_
- $w MED00174670 $t Genetic testing and molecular biomarkers $x 1945-0257 $g Roč. 22, č. 2 (2018), s. 127-134
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29425068 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20200923170546 $b ABA008
- 999 __
- $a ok $b bmc $g 1339426 $s 1030322
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 22 $c 2 $d 127-134 $i 1945-0257 $m Genetic testing and molecular biomarkers $n Genet Test Mol Biomarkers $x MED00174670
- GRA __
- $a NV16-31173A $p MZ0
- LZP __
- $a Pubmed-20181008